✦ LIBER ✦

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial

✍ Scribed by Paul W. Armstrong; Cynthia M. Westerhout; Frans Van de Werf; Robert M. Califf; Robert C. Welsh; Robert G. Wilcox; Jeffrey A. Bakal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The assessment of the safety and efficac

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Age, outcomes, and treatment effects of

✍ Peter R. Sinnaeve; Yao Huang; Kris Bogaerts; Alec Vahanian; Jennifer Adgey; Paul 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Unraveling the spectrum of left bundle b

✍ Hussam Al-Faleh; Yuling Fu; Galen Wagner; Shaun Goodman; Elena Sgarbossa; Christ 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Efficacy of tenecteplase in combination

✍ Peter R Sinnaeve; John H Alexander; Kris Bogaerts; Ann Belmans; Lars Wallentin; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Economic analysis of the Assessment of t

✍ Padma Kaul; Paul W. Armstrong; Patricia A. Cowper; Eric L. Eisenstein; Christoph 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Efficacy and safety of tenecteplase in c

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB